Model Number 3300TFX |
Device Problems
Gradient Increase (1270); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Endocarditis (1834); Insufficient Information (4580)
|
Event Date 06/16/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress.Therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis.And if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was reported, that a patient with a 25mm 3300tfx aortic valve underwent a valve-in-valve procedure.After an implant duration of 8 years and 2 months, due to unknown reasons.The procedure was performed successfully with a 26mm 9750tfx transcatheter valve.The patient post procedure in recovery.
|
|
Manufacturer Narrative
|
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Prosthetic endocarditis is a serious complication of valve replacement and repair surgeries despite improvements in prosthesis types, surgical techniques, and infection control measures.This infection is categorized into early (onset at 60 days or less post-implant) and intermediate/late (onset greater than 60 days post-implant).Intermediate/late onset occurs due to the implant being seeded from an infection or microbial contamination from elsewhere in the body and is not related to the sterilization or packaging process.In this case the onset was greater than 60 days post-implant.The most likely cause is patient factors.H11 corrected data: based on the new information received, this event is no longer considered reportable.
|
|
Event Description
|
It was reported and learned through investigation that a patient with a 25mm 3300tfx aortic valve underwent a valve-in-valve procedure after an implant duration of 8 years and 2 months due to streptococcus viridans endocarditis with stenosis.The patient presented with shortness of breath and lightheadedness.The procedure was performed successfully with a 26mm 9750tfx transcatheter valve.The patient was in stable conditions post procedure.
|
|
Search Alerts/Recalls
|